Skip to content
Catalyst

PapersPMID:35877734

Antioxidant Efficacy of a Spirulina Liquid Extract on Oxidative Stress Status and Metabolic Disturbances in Subjects with Metabolic Syndrome.

Marine drugs2022The record ↗

  1. Finding, moderate evidencelowersTriglycerides

What moved

1 findingHow to read these marks →
  • Decreases triglycerides

    moderatereplicated ×4

    “Mean triglycerides levels were significantly decreased in the Spirulysat® group compared to placebo at V3 (1.23 ± 0.57 vs. 1.97 ± 0.80 g/L, p = 0.003).”
    Study
    RCT
    Duration
    3 months
    Interests
    Industry funded
    Dose studied
    2 vials of 10 mL per day before breakfast, 12 weeks; the paper states a low dose of about 20 mg per day (2 x 10 mg)
    Population
    Adults aged 18-65 with metabolic syndrome and BMI 25-35; Spirulysat versus placebo of identical appearance and packaging; end-of-study visit V3 (12 weeks)

Study record

Design
randomised controlled trial
Species
human
Population
adults aged 18 to 65 years with metabolic syndrome, BMI between 25 and 35 kg/m2
Participants
40
Comparator
placebo
Duration
84 days
Endpoints measured
38